Sign in

TMED

EURONEXT:TMED

EGF Theramed Health Corp.

  • Stock

Last Close

0.09

06/08 14:32

Market Cap

1.20M

Beta: -

PE Ratio

−6.58

PFCF: −16.19

OverviewAnalysisFinancialsFilingspeopleAPIChartData

  • market

    STOCKS

  • ipo date

    Jul 05, 2013

EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.

peer of

Earnings

Earnings per Share (Estimate*)

-4000-3000-2000-10002013-04-302015-03-312017-03-312019-03-312021-03-31

Revenue (Estimate*)

0.000.000.010.010.012013-04-302015-03-312017-03-312019-03-312021-03-31

*Estimate based on analyst consensus